Supplement: The Art of Adapting to MS

The Art of Adapting to MS By Kirsten Weir © Matthew Robbins Maggie McPhersun stands in front of a canvas that she painted, a whimsical print of swirling lines and bright colors. Completing it, she says, was "incredibly painful emotionally." McPhersun, 51, is a registered nurse from Brunswick, Maine. She's also an artist, and she once took commissions, painting intricate portraits - before multiple scle

Written byKirsten Weir
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Maggie McPhersun stands in front of a canvas that she painted, a whimsical print of swirling lines and bright colors. Completing it, she says, was "incredibly painful emotionally." McPhersun, 51, is a registered nurse from Brunswick, Maine. She's also an artist, and she once took commissions, painting intricate portraits - before multiple sclerosis (MS) took away her ability to render faces in fine detail. Her latest painting is her first attempt at a looser style, more suitable for shaky hands and blurry vision.

Less than three years ago, a physician diagnosed MS in McPhersun, but the symptoms, she believes, started two decades ago. Exhaustion hit her often, and she grew depressed every summer. Periodically, she choked on pieces of food. Doctors diagnosed chronic fatigue or depression. Then, she began swaying, listing to the right as she walked. She became embarrassed to take strolls around Portland's Back Cove, which she once ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies